Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Patient-specific risk factors for BCC, SCC examined in study

Scott J et al. Presentation at American College of Mohs Surgery, May 2018.

Publish date:: June 27, 2018

Key clinical point: Individualized risk assessment for skin cancer after hematopoietic cell transplantation may be close at hand.

Major finding: Photodamage documented on examination more than triples the risk of developing nonmelanoma skin cancer after hematopoietic cell transplantation.

Study details: A multicenter retrospective study of 876 hematopoietic cell recipients followed for a mean of 6.1 years.

Disclosures: The presenter reported having no financial conflicts related to the study, which was conducted without commercial support.

Read the article.

Citation:

Scott J et al. Presentation at American College of Mohs Surgery, May 2018.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in ALL

In high-risk first relapse ALL, blinatumomab seen superior to consolidation chemo,

Well tolerated with promising responses in ALL/LL: Venetoclax plus navitoclax plus chemotherapy,

Highly effective in Ph-negative B-cell ALL: Hyper-CVAD with sequential blinatumomab,

Study: Complications from childhood ALL and its treatment are common, but can be managed,